Jared W. Fennell
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Computational Drug Discovery Methods, Analytical Chemistry and Chromatography, Chemical Synthesis and Analysis
Most-Cited Works
- → A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies(2017)33 cited
- → Approaches and Considerations for the Investigation and Synthesis of N-Nitrosamine Drug Substance-Related Impurities (NDSRIs)(2023)32 cited
- → Use of Modeling and Process Analytical Technologies in the Design of a Catalytic Amination Reaction: Understanding Oxygen Sensitivity at the Lab and Manufacturing Scales(2013)27 cited
- → New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities(2019)23 cited
- → The Role of New Technologies in Defining a Manufacturing Process for PPARα Agonist LY518674(2009)17 cited
- → An Alternative Indazole Synthesis for Merestinib(2018)13 cited
- → An Industrial Approach to Using Artificial Intelligence and Natural Language Processing for Accelerated Document Preparation in Drug Development(2020)10 cited
- → Establishing Best Practice for the Application and Support of Solubility Purge Factors(2023)9 cited
- → Industrial Case Studies Demonstrating Applicability of ICH M7 Control Options 3 and 4 for Nitrosamine Control(2025)4 cited
- → Use of Silyl Ester and Enamine Protection for an Efficient Alternate Synthesis of (1S,2S,5R,6S)-2-[(2′S)-(2′-Amino)propionyl]aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY544344·HCl)(2006)1 cited